Isabella Sperduti
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 51
- Cancer Treatment and Pharmacology 50
- HER2/EGFR in Cancer Research 38
- Cancer Immunotherapy and Biomarkers 21
- Lung Cancer Research Studies 21
- Cancer Research top 1%
- Breast Cancer Treatment Studies 36
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 50
- Gastric Cancer Management and Outcomes 25
- Hepatology top 2%
- Dermatology top 1%
- Co-authors
- Emilio BriaMichèle MilellaDiana GiannarelliMarcella MottoleseFrancesco CognettiFederica CupponeGiampaolo TortoraAlessandra Fabi
- Journals
- Nucleic Acids Research (1 paper)Journal of Clinical Investigation (1 paper)Journal of Clinical Oncology (38 papers)
- Partner nations
- ItalyMalaysiaUnited States
In The Last Decade
Isabella Sperduti
379 papers receiving 8.9k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Oncology 4.0k
- Cancer Research 1.4k
- Pulmonary and Respiratory Medicine 2.4k
- Hepatology 453
- Dermatology 463
Countries citing papers authored by Isabella Sperduti
This map shows the geographic impact of Isabella Sperduti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabella Sperduti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabella Sperduti more than expected).
Fields of papers citing papers by Isabella Sperduti
This network shows the impact of papers produced by Isabella Sperduti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabella Sperduti. The network helps show where Isabella Sperduti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Isabella Sperduti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 16 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 19 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 16 | |
| 11 | 2020 | 2 | |
| 12 | 2020 | 2 | |
| 13 | 2020 | 13 | |
| 14 | 2019 | 28 | |
| 15 | 2017 | 48 | |
| 16 | 2016 | 9 | |
| 17 | Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder | 2015 | 3 |
| 18 | 2015 | 0 | |
| 19 | 2011 | 72 | |
| 20 | 2008 | 1 |
About Isabella Sperduti
Isabella Sperduti is a scholar working on Oncology, Microbiology and Cancer Research, having authored 395 papers that have together received 9.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (51 papers), Lung Cancer Treatments and Mutations (50 papers), Cancer Treatment and Pharmacology (50 papers), HER2/EGFR in Cancer Research (38 papers), Breast Cancer Treatment Studies (36 papers), Gastric Cancer Management and Outcomes (25 papers), Cancer Immunotherapy and Biomarkers (21 papers) and Lung Cancer Research Studies (21 papers). The work is most often cited by research in Oncology (4.0k citations), Cancer Research (1.4k citations) and Pulmonary and Respiratory Medicine (2.4k citations). Isabella Sperduti has collaborated with scholars based in Italy, Malaysia and United States. Frequent co-authors include Emilio Bria, Michèle Milella, Diana Giannarelli, Marcella Mottolese, Francesco Cognetti, Federica Cuppone, Giampaolo Tortora, Alessandra Fabi, Paolo Carlini and Sara Pilotto. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.